These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 27597180)
1. Relative Abundance of apoE and Aβ1-42 Associated with Abnormal Prion Protein Differs between Creutzfeldt-Jakob Disease Subtypes. Moore RA; Choi YP; Head MW; Ironside JW; Faris R; Ritchie DL; Zanusso G; Priola SA J Proteome Res; 2016 Dec; 15(12):4518-4531. PubMed ID: 27597180 [TBL] [Abstract][Full Text] [Related]
2. Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease. Debatin L; Streffer J; Geissen M; Matschke J; Aguzzi A; Glatzel M Neurodegener Dis; 2008; 5(6):347-54. PubMed ID: 18349519 [TBL] [Abstract][Full Text] [Related]
3. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients. Moore RA; Head MW; Ironside JW; Ritchie DL; Zanusso G; Choi YP; Priola SA PLoS Pathog; 2016 Feb; 12(2):e1005416. PubMed ID: 26840342 [TBL] [Abstract][Full Text] [Related]
4. Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study. Cali I; Cohen ML; Haik S; Parchi P; Giaccone G; Collins SJ; Kofskey D; Wang H; McLean CA; Brandel JP; Privat N; Sazdovitch V; Duyckaerts C; Kitamoto T; Belay ED; Maddox RA; Tagliavini F; Pocchiari M; Leschek E; Appleby BS; Safar JG; Schonberger LB; Gambetti P Acta Neuropathol Commun; 2018 Jan; 6(1):5. PubMed ID: 29310723 [TBL] [Abstract][Full Text] [Related]
14. Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease. Varges D; Jung K; Gawinecka J; Heinemann U; Schmitz M; von Ahsen N; Krasnianski A; Armstrong VW; Zerr I J Alzheimers Dis; 2011; 23(4):717-26. PubMed ID: 21157024 [TBL] [Abstract][Full Text] [Related]
15. Comparative Study of Prions in Iatrogenic and Sporadic Creutzfeldt-Jakob Disease. Xiao X; Yuan J; Qing L; Cali I; Mikol J; Delisle MB; Uro-Coste E; Zeng L; Abouelsaad M; Gazgalis D; Martinez MC; Wang GX; Brown P; Ironside JW; Gambetti P; Kong Q; Zou WQ J Clin Cell Immunol; 2014 Aug; 5(4):. PubMed ID: 25419482 [TBL] [Abstract][Full Text] [Related]
16. Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. Jaunmuktane Z; Mead S; Ellis M; Wadsworth JD; Nicoll AJ; Kenny J; Launchbury F; Linehan J; Richard-Loendt A; Walker AS; Rudge P; Collinge J; Brandner S Nature; 2015 Sep; 525(7568):247-50. PubMed ID: 26354483 [TBL] [Abstract][Full Text] [Related]
17. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease. Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604 [TBL] [Abstract][Full Text] [Related]
18. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Cali I; Castellani R; Alshekhlee A; Cohen Y; Blevins J; Yuan J; Langeveld JP; Parchi P; Safar JG; Zou WQ; Gambetti P Brain; 2009 Oct; 132(Pt 10):2643-58. PubMed ID: 19734292 [TBL] [Abstract][Full Text] [Related]
19. Highly infectious CJD particles lack prion protein but contain many viral-linked peptides by LC-MS/MS. Kipkorir T; Tittman S; Botsios S; Manuelidis L J Cell Biochem; 2014 Nov; 115(11):2012-21. PubMed ID: 24933657 [TBL] [Abstract][Full Text] [Related]